Ads
related to: pet scanner cancer- Prostate Cancer Resources
Visit the patient website to
download the patient brochure.
- Talk To Your Doctor
Review questions to ask your doctor
about prostate cancer imaging.
- Prostate Cancer Info
Visit patient site to find more
information about prostate cancer.
- Imaging Site Locator
Find the nearest imaging
center for this imaging agent.
- Prostate Cancer Resources
Search results
Results From The WOW.Com Content Network
Cardiac PET scanner. [ edit on Wikidata] Positron emission tomography ( PET) [ 1] is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption.
Positron emission tomographyโcomputed tomography (better known as PET-CT or PET/CT) is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, to acquire sequential images from both devices in the same session, which are combined into a single superposed (co-registered) image.
A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand. After injection, imaging of positron emitters such as gallium-68 ( 68 ...
This is a list of positron emission tomography (PET) radiotracers. These are chemical compounds in which one or more atoms have been replaced by a short-lived, positron emitting radioisotope. Cardiology
Infobox references. [18F]Fluorodeoxyglucose ( INN ), or fluorodeoxyglucose F 18 ( USAN and USP ), also commonly called fluorodeoxyglucose and abbreviated [18F]FDG, 2- [18F]FDG or FDG, is a radiopharmaceutical, specifically a radiotracer, used in the medical imaging modality positron emission tomography (PET).
PET response criteria in solid tumors ( PERCIST) is a set of rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment, using positron emission tomography (PET). The criteria were published in May 2009 in the Journal of Nuclear Medicine (JNM). [1]
Ads
related to: pet scanner cancer